Matsumoto, Japan

Denichi Momose

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 58(Granted Patents)


Location History:

  • Matsumoto, JP (1980 - 1982)
  • Nagano, JP (1986)

Company Filing History:


Years Active: 1980-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Denichi Momose: Innovator in Pharmaceutical Chemistry

Introduction

Denichi Momose is a notable inventor based in Matsumoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazole derivatives. With a total of 3 patents, his research has focused on developing compounds with therapeutic applications.

Latest Patents

Momose's latest patents include groundbreaking work on imidazole derivatives and their pharmaceutical uses. One of his notable inventions involves imidazole derivatives that exhibit a strong inhibitory effect on thromboxane synthetase from human or bovine platelet microsomes. These compounds are particularly useful in treating conditions such as inflammation, hypertension, thrombus, cerebral apoplexy, and asthma. Another patent focuses on imidazole compounds that also inhibit thromboxane synthetase from rabbit platelet microsomes, further emphasizing their potential as therapeutic agents.

Career Highlights

Throughout his career, Denichi Momose has worked with prominent companies in the pharmaceutical industry, including Kissei Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. His work has been instrumental in advancing the understanding and application of imidazole derivatives in medicine.

Collaborations

Momose has collaborated with esteemed colleagues such as Kinji Iizuka and Yukio Kamijo. These partnerships have contributed to the success of his research and the development of innovative pharmaceutical solutions.

Conclusion

Denichi Momose's contributions to pharmaceutical chemistry through his patents on imidazole derivatives highlight his role as a key innovator in the field. His work continues to impact the development of therapeutic agents for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…